MedTrace Logo

Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells

NCT02272530 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-02-16

No results posted yet for this study

Summary

The aim of this study is to investigate wether change in endothelial nitric oxid synthase of blood cells (erythrocytes and peripheral blood mononuclear cells (PBMC)) has an influence on development and progression of cardiovascular diseases.

Conditions

  • Red Blood Cell
  • Peripheral Blood Mononuclear Cell
  • Endothelial NO-synthase

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Principal Investigators

  • Malte Kelm, Prof. MD · Department of Cardiology, Pneumology and Angiology, University Hospital Duesseldorf

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02272530 on ClinicalTrials.gov